Astrana Health, Inc. (ASTH) financials: revenue, earnings and cash flow
Fiscal 2020–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Astrana Health’s revenue went from $687M in fiscal 2020 to $3.2B in fiscal 2025, growth of about 35.9% a year.
Net income in fiscal 2025 was $22M, a net margin of 0.7%; the best year in this period was 2021 with $69M.
Over the twelve months to September 30, 2026, revenue was $3.9B and net income $53M.
Free cash flow was $104M in fiscal 2025 and positive in 6 of the 6 years shown.
The diluted share count rose 32% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.2B | $2.0B | $1.4B | $1.1B | $774M | $687M |
| Gross profit | — | — | — | — | — | $178M | $148M |
| Operating income | $121M | $79M | $89M | $85M | $104M | $98M | $81M |
| Net income | $53M | $22M | $43M | $61M | $45M | $69M | $38M |
| EPS (diluted) | $1.08 | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 |
| R&D | — | — | — | — | — | — | — |
| Revenue growth | — | +56.4% | +46.7% | +21.2% | +47.8% | +12.6% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $114M | $115M | $52M | $68M | $82M | $70M | $46M |
| Capital spending | -$15M | -$10M | -$8M | -$29M | -$23M | -$19M | -$1M |
| Free cash flow | $99M | $104M | $44M | $40M | $59M | $51M | $45M |
| Dividends paid | $3M | $8M | $4M | $62M | $14M | $31M | $51M |
| Buybacks | $19M | $26M | $900000 | $10M | $9M | $6M | $537000 |
| Stock-based pay | $49M | $39M | $35M | $22M | $16M | $7M | $3M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash | — | $429M | $291M | $296M | $294M | $287M | $261M |
| Debt | — | $1.1B | $474M | $323M | $231M | $204M | $265M |
| Equity | — | $779M | $713M | $614M | $543M | $448M | $331M |
| Total assets | — | $2.2B | $1.4B | $933M | $966M | $867M | $817M |
| Shares (diluted) | 50M | 49M | 48M | 47M | 46M | 45M | 37M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | 23.0% | 21.5% |
| Operating margin | 3.1% | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% |
| Net margin | 1.4% | 0.7% | 2.1% | 4.4% | 4.0% | 8.9% | 5.5% |
| FCF margin | 2.5% | 3.3% | 2.2% | 2.9% | 5.2% | 6.6% | 6.6% |
| ROIC | — | 2.5% | 4.7% | 5.8% | 7.1% | 8.9% | 9.2% |
| ROE | — | 2.9% | 6.0% | 9.9% | 8.3% | 15.4% | 11.4% |
Frequently asked questions
What is Astrana Health’s annual revenue?
$3.2B in fiscal 2025 and $3.9B over the twelve months to September 30, 2026.
How much profit does Astrana Health make?
Net income was $22M in fiscal 2025 (net margin 0.7%).
Is Astrana Health’s revenue growing?
Yes: revenue rose 56.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.